WINKAST-LC KID SYRUP
MRP: 75
Packaging: 30ML
Pack Type: suspension
Composition:
Montelukast 4mg + Levocetirizine Dihydrochloride IP 2.5mg
Indication:
Allergic rhinitis (seasonal or perennial) | Urticaria Symptoms of allergic reactions
Description:
Montelukast 4mg + Levocetirizine Dihydrochloride 2.5mg is a combination medication used to treat seasonal allergic rhinitis, chronic urticaria, and asthma-related symptoms in pediatric patients. This formulation provides synergistic action: Levocetirizine, a second-generation antihistamine, blocks histamine receptors to reduce sneezing, runny nose, and itchy eyes; while Montelukast, a leukotriene receptor antagonist, prevents airway inflammation and bronchospasm.
It is available in syrup, tablet, or dispersible tablet form depending on the age group and prescription.
Tags:
- Dual-action relief from allergic and respiratory symptoms
- Non-sedating, safe for daytime use
- Controls symptoms like sneezing, runny nose, wheezing, and itching
- Prevents asthma flare-ups in allergy-prone children
- Available in easy-to-administer pediatric forms
Usage Information
Dosage
Syrup (2–5 years): 2.5 mL once daily DT/Tablets (6–12 years): 1 tablet once daily Adolescents: As per physician recommendation Preferably administered in the evening Can be taken with or without food Always follow pediatrician’s advice for correct dosage.
Side Effects
Headache Dry mouth Mild drowsiness or dizziness Nausea, abdominal pain Behavioral changes (rare in children) Skin rash (in rare cases)
Contraindications
Hypersensitivity to any component Severe renal impairment (Levocetirizine caution) Children below 2 years (unless specifically advised by a doctor)
Availability
Montelukast Levocetirizine kids tablet, allergy syrup for children, anti-allergic medicine for pediatric use, levocetirizine dihydrochloride 2.5 mg, montelukast 4mg